British cannabis company Ananda Developments (AQSE:ANA) PLC has been boosted by the award of an import licence by the Israeli government, as the company seeks to stabilise 65 cannabis strains for commercial scale medical markets.
Cannabis plants grown in the UK by Ananda subsidiary DJT Plants Limited are now approved for import by Cannasoul Analytics, an Israeli research company run by Professor Dedi Meiri.
The company noted that the licence was sought early in its venture with Cannasoul Analytics as it planned to use the process to ensure that DJT Plants has a clear understanding of all requirements for moving cannabis flower, a controlled drug under the UK Government’s Misuse of Drugs Act 1971, from the UK into Israel. Corresponding UK export licences will be sought under the relevant UK legislation nearer to the time of export.
“We don’t underestimate the complexity of the work required to grow medical cannabis in the UK,” said chief executive Melissa Sturgess. “The prize, however, is big; both from a patient care and a financial perspective.
“Delivering the best quality, consistent medical cannabis medicine to UK and international patients is our clear objective.
“We continue to work in a focused and diligent manner towards achieving our goals.”